Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

AbbVie Announces Initiation of Phase 3 Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma
AbbVie Announces Initiation of Phase 3 Study of Venetoclax in Patients with Relapsed or Refractory Multiple Myeloma
NORTH CHICAGO, IL, USA  - July 28, 2016 - AbbVie (ABBV), a global biopharmaceutical company, today announced the initiation of a Phase 3 clinical trial to study the safety and efficacy of ven...
Bayer Q2 shows pharma, consumer divergence in China, emerging markets
Bayer Q2 shows pharma, consumer divergence in China, emerging markets
Bayer Healthcare and Consumer showed divergence in China and emerging markets in the second quarter as integrating acquisitions in the consumer unit continued as a challenge, while leading therapies X...
Pfizer planning yet another plant expansion
Pfizer planning yet another plant expansion
In yet another expansion of its manufacturing operations, Pfizer ($PFE) plans to lay out nearly $150 million to build a sterile manufacturing facility and warehouse at its site near Kalamazoo,...
New drug slows Alzheimer's progress, research reveals
New drug slows Alzheimer's progress, research reveals
Brain deterioration caused by Alzheimer's has been delayed with a drug for the first time, researchers have announced.
UK drugs giant GSK invests £275m despite Brexit
UK drugs giant GSK invests £275m despite Brexit
Drugmaker GlaxoSmithKline on Wednesday revealed plans to invest £275 million into three of its British manufacturing sites, shrugging off Brexit worries.
Teva expect to close $40.5B Allergan generic deal next week
Teva expect to close $40.5B Allergan generic deal next week
Israeli drugmaker Teva, the largest generic drug company in the world, said Wednesday it expects to complete its $40.
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR™ (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C
NORTH CHICAGO, IL, USA I July 25, 2016 I AbbVie (ABBV), a global biopharmaceutical company, today announced that the U.
Tokai Pharmaceuticals Announces Clinical Update
Tokai Pharmaceuticals Announces Clinical Update
                galeterone                                              enzalutamideTokai Pharmaceuticals Inc.
Alzheon Presents Positive Results of ALZ-801 Clinical Studies that Lead to Advancement to Pivotal Phase 3 Study in Alzheimer's Patients with APOE4/4 Homozygous Genotype
Alzheon Presents Positive Results of ALZ-801 Clinical Studies that Lead to Advancement to Pivotal Phase 3 Study in Alzheimer's Patients with APOE4/4 Homozygous Genotype
FRAMINGHAM, MA, USA - July 25, 2016 - Alzheon Inc.
EU watchdog flags faulty generic drug data, backs sales halt
EU watchdog flags faulty generic drug data, backs sales halt
The European Medicines Agency (EMA) recommended suspending sales of some generic drugs after a review found that data collected by a contract research company in India for their approval was u...
Sunovion Announces Results of Phase 3 Long-Term Safety Study Showing SUN-101/eFlow® (glycopyrrolate) Was Well-Tolerated in People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
Sunovion Announces Results of Phase 3 Long-Term Safety Study Showing SUN-101/eFlow® (glycopyrrolate) Was Well-Tolerated in People with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease (COPD)
MARLBOROUGH, MA, USA - July 22, 2016 - Sunovion Pharmaceuticals Inc.
FDA sends stern warning to Glaxo over contamination at a penicillin plant
FDA sends stern warning to Glaxo over contamination at a penicillin plant
GlaxoSmithKline is recalling a “small” number of batches of its Bactroban antibiotic following a harsh rebuke from US regulators about contamination at a key plant.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand